Our model, supported by primary experimental observations, suggests that cPLA2α-dependent PGE2/EP4 signaling is important for maintaining the psoriatic phenotype of KCs under cytokine stimulation, thus providing a therapeutic mode of action for the cPLA2α inhibitor AVX001 in psoriasis. This evidence concerns the gene TBCE and psoriasis.